XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Components used to Calculate Basic and Diluted Earnings Per Share
The following is a summary of the components used to calculate basic and diluted earnings per share (in thousands, except per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Numerator:
Net (loss) income$(11,760)$(3,556)$(9,100)$37,975 
Adjusted for:
Distributions to and accretion of redeemable non-controlling interests(656)(656)(1,970)(1,970)
Preferred dividends(3,968)(3,968)(11,906)(11,906)
Losses attributable to non-controlling interests in joint ventures3,565 3,274 3,051 4,011 
Dividends paid on unvested time-based restricted stock(113)(85)(324)(225)
Allocation of loss (income) to participating securities
1,415 719 2,211 (3,655)
Numerator for (loss) income per common stockholder - basic(11,517)(4,272)(18,038)24,230 
Adjusted for:
Interest rate effect on assumed conversion of convertible debt— — — 3,244 
Allocation of income to participating securities (1)
— — — 3,864 
Numerator for (loss) income per common stockholder - diluted$(11,517)$(4,272)$(18,038)$31,338 
Denominator:
Weighted average common shares outstanding - basic105,889 106,033 107,169 105,891 
Adjusted for:
Dilutive effect of equity-based compensation awards— — — 2,551 
Effect of assumed conversion of convertible debt— — — 25,614 
Effect of assumed conversion of Operating Partnership units— — — 15,947 
Weighted average common shares outstanding - diluted105,889 106,033 107,169 150,003 
Net (loss) income per share available to common stockholders:
Basic$(0.11)$(0.04)$(0.17)$0.23 
Diluted$(0.11)$(0.04)$(0.17)$0.21 

(1)    Balances reflect potentially dilutive securities issuable based on the estimated vesting of performance-based restricted stock assuming that the reporting date is the vesting date and unvested time-based restricted stock using the treasury stock method. These shares were not included for the three months ended September 30, 2025 and 2024, and the nine months ended September 30, 2025 since their inclusion would have been anti-dilutive.